Other promising biomarkers have been suggested for diagnosis, monitoring and prognosis of traumatic brain injury (TBI) such as microtubule-associated protein-2 (MAP2, neuron-specific enolase (NSE), myelin basic protein (MBP), tau, s100β and neurofilament heavy chain protein (NF-H) [4–6]. This evidence concerns the gene MBP and brain injury.